Thermedical SERF Ablation System Earns FDA Breakthrough Device Designation
Diagnostic and Interventional Cardiology,
– Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), announced that it has…
– Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), announced that it has…
WALTHAM, Mass.–(BUSINESS WIRE)–May 19, 2020–, a developer of thermal-ablation medical systems to treat ventricular tachycardia (V…
13:00 UTC WALTHAM, Mass.--( BUSINESS WIRE )-- Thermedical, a developer of thermal-ablation medical systems to treat ventricular…
, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), today announced that it has received…
WALTHAM, Mass.--( BUSINESS WIRE )-- Thermedical ®, a developer of thermal-ablation medical systems to treat ventricular…
WALTHAM, Mass.--(BUSINESS WIRE)-- Thermedical® announced today that the U.S. Food and Drug Administration (FDA) has approved…
WALTHAM, Mass.--(Business Wire)--Thermedical® announced today that the U.S. Food and Drug Administration (FDA) has approved its…
- Thermedical ® announced today that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device…
Thermedical ® announced today that the U.S. Food and Drug Administration ( FDA ) has approved its Investigational Device…
WALTHAM, Mass.--( BUSINESS WIRE )-- Thermedical ® announced today that the U.S.
Action Points Note that this observational study of individuals undergoing ablation for recurrent ventricular tachycardia…